701 related articles for article (PubMed ID: 24997886)
1. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
[TBL] [Abstract][Full Text] [Related]
2. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
Azougagh M; Elkarbane M; Bakhous K; Issmaili S; Skalli A; Iben Moussad S; Benaji B
Ann Pharm Fr; 2016 Sep; 74(5):358-69. PubMed ID: 27475309
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin.
Silva TD; Oliveira MA; de Oliveira RB; Vianna-Soares CD
J Chromatogr Sci; 2012 Oct; 50(9):831-8. PubMed ID: 22689902
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous liquid chromatographic determination of ezetimibe and simvastatin in pharmaceutical products.
Oliveira PR; Barth T; Todeschini V; Dalmora SL
J AOAC Int; 2007; 90(6):1566-72. PubMed ID: 18193733
[TBL] [Abstract][Full Text] [Related]
6. Rapid and sensitive simultaneous determination of ezetimibe and simvastatin from their combination drug products by monolithic silica high-performance liquid chromatographic column.
Hefnawy M; Al-Omar M; Julkhuf S
J Pharm Biomed Anal; 2009 Oct; 50(3):527-34. PubMed ID: 19487095
[TBL] [Abstract][Full Text] [Related]
7. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a reversed-phase HPLC method for the simultaneous analysis of simvastatin and tocotrienols in combined dosage forms.
Ali H; Nazzal S
J Pharm Biomed Anal; 2009 May; 49(4):950-6. PubMed ID: 19286339
[TBL] [Abstract][Full Text] [Related]
9. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
[TBL] [Abstract][Full Text] [Related]
10. Development of validated stability indicating assay method for simultaneous estimation of metformin hydrochloride and vildagliptin by RP-HPLC.
Satheeshkumar N; Pradeepkumar M; Shanthikumar S; Rao VJ
Drug Res (Stuttg); 2014 Mar; 64(3):124-9. PubMed ID: 24081820
[TBL] [Abstract][Full Text] [Related]
11. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
Vuletić M; Cindrić M; Koruznjak JD
J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
[TBL] [Abstract][Full Text] [Related]
12. Application of ion-trap mass spectrometry for identification and structural determination of an unknown impurity in simvastatin.
Reddy GV; Kumar AP; Reddy BV; Sreeramulu J
Pharmazie; 2009 Oct; 64(10):638-41. PubMed ID: 19947164
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of spectrophotometeric method for simultaneous determination of simvastatin and ezetimibe in tablet formulations.
Balaji S; Sunitha A
Pak J Pharm Sci; 2010 Oct; 23(4):375-8. PubMed ID: 20884449
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a liquid chromatographic method for the simultaneous determination of aniracetam and its related substances in the bulk drug and a tablet formulation.
Papandreou G; Zorpas K; Archontaki H
J Pharm Biomed Anal; 2011 Nov; 56(3):615-22. PubMed ID: 21742456
[TBL] [Abstract][Full Text] [Related]
15. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.
Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of reversed phase high performance liquid chromatographic method for determination of moxonidine in the presence of its impurities.
Milovanović S; Otašević B; Zečević M; Zivanović L; Protić A
J Pharm Biomed Anal; 2012 Feb; 59():151-6. PubMed ID: 22071445
[TBL] [Abstract][Full Text] [Related]
17. Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
Jaber AM; Al Sherife HA; Al Omari MM; Badwan AA
J Pharm Biomed Anal; 2004 Oct; 36(2):341-50. PubMed ID: 15496327
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantitation of aspirin, amlodipine and simvastatin in a fixed dose combination of encapsulated tablet formulation by HPLC-UV method.
Sultan F; Shoaib MH; Yousuf RI; Ahmed FR; Salam FA; Nasiri MI; Khan MA; Manzoor S
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1553-8. PubMed ID: 25176250
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
